Idenix sues Gilead over patent

|About: Idenix Pharmaceuticals... (IDIX)|By:, SA News Editor

Idenix Pharmaceuticals (IDIX) files patent infringement lawsuit against Gilead Sciences (GILD) in France, Germany and the UK.

The suit pertains to European patent EP 1 523 489 that covers 2-methyl-2-fluoro nucleosides for the treatment of Hep C.

The company seeks remedies regarding Gilead's commercial activities with its drugs containing sofosbuvir.